FIELD: biotechnology. SUBSTANCE: human immunoglobulin showing specificity to human protein L-selectin is chimeric immunoglobulin having regions that determine complementarity (CDR) corresponding to CDR-regions of murine donor immunoglobulin and carcass regions of variable site of heavy and light chain of human acceptor immunoglobulin and specifically binding with human L-selectin (affinity constant is 107M-1). Invention ensures to prepare nonimmunogeneous for human immunoglobulin showing specificity to protein L-selectin. EFFECT: improved method of preparing. 19 cl, 1 tbl, 6 dwg, 5 ex
Title | Year | Author | Number |
---|---|---|---|
RECOMBINANT ANTIBODY, POLYNUCLEOTIDE (VARIANTS), METHOD OF PREPARING HEAVY AND/OR LIGHT CHAINS OF RECOMBINANT ANTIBODY (VARIANTS) | 1989 |
|
RU2126046C1 |
HUMANIZED ANTIBODIES THAT RECOGNIZE VEROTOXIN II AND CELL LINE PRODUCING THEREOF | 1999 |
|
RU2217166C2 |
HUMANIZED ANTIBODIES AND THEIR UTILIZATION | 1994 |
|
RU2139934C1 |
ANTI-THROMBOTIC AGENT AND HUMANIZED MONOCLONAL ANTIBODY RAISED AGAINST VON WILLEBRAND FACTOR | 1999 |
|
RU2223785C2 |
HUMANISED ANTI-FACTOR D ANTIBODIES AND USE THEREOF | 2007 |
|
RU2474589C2 |
HUMANISED ANTI-FACTOR D ANTIBODIES AND APPLICATIONS THEREOF | 2012 |
|
RU2678802C2 |
HUMANIZED ANTIBODY TO BETA AMYLOID | 2013 |
|
RU2668161C2 |
IMMUNOGLOBULINS K HUMAN CD52 | 2010 |
|
RU2603743C2 |
HUMANIZED ANTIBODY TO CONFORMATIONAL C3 EPITOPE CONSTITUENT OF HUMAN COMPLEMENT, DNA SEQUENCE (VERSIONS), EXPRESSION VECTOR CONTAINING DNA SEQUENCE (VERSIONS), AND OVARIAN CELLS' STRAIN OF CHINESE HAMSTER CHO-HUMC34-PRODUCER OF THIS HUMANIZED ANTIBODY | 2016 |
|
RU2630647C1 |
CHIMERIC AND HUMANISED INTEGRIN α5β1 ANTIBODIES MODULATING ANGIOGENESIS | 2003 |
|
RU2346701C2 |
Authors
Dates
2000-06-27—Published
1993-11-30—Filed